USPTO serial 79413512
Serial No. 79413512
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAVACHE, LINDA M
- Law office
- TMEG LAW OFFICE 106
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79413512?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, medical and veterinary preparations; pharmaceutical, medical and veterinary preparations in the field of microbiome modulating therapeutics; pharmaceutical preparations for use in targeted pharmaceutical therapies; pharmaceutical preparations and products for the treatment of gastrointestinal disorders and diseases; biotechnological preparations for medical use; biological compounds for use in targeted pharmaceutical therapies; proteins with diagnostic and therapeutic uses; chemical and enzyme preparations for medical or veterinary purposes; reagents and substances for use in testing for medical and veterinary purposes; drug delivery agents that facilitate the delivery of pharmaceutical preparations; intestinal microbiome pharmaceutical preparations; nutritive agents for processing living cells for medical use; reagents for use in biological processing for medical purposes; solutions for medical use in the preservation of human excreta; preservatives for maintaining the viability of micro-organisms in cultures for medical purposes; probiotic bacterial formulations for medical use; clinical medical reagents; diagnostic and testing preparations for clinical, medical and medical laboratory use; diagnostic reagents and assay components for clinical, medical and medical laboratory use; enzymes for medical purposes; yeast for intracellular production of recombinant proteins; yeast for pharmaceutical purposes; dietary supplements; food supplements; topical gels for medical and therapeutic use; intestinal microbiome medicinal preparations; pharmaceuticals or therapeutic preparations in the fields of microbiology, genetics, the human immune system, the human gut microbiome or gastrointestinal health; diagnostic preparations for use in the fields of microbiology, genetics, the human immune system, the human gut microbiome or gastrointestinal health; medical preparations for use in connection with intestinal microbiota transfer; chemical preparations and reagents for medical purposes; diagnostic biomarkers for in vitro and in vivo testing for medical use. | SECTION 70 - CANCELLED | — |
| 042 | Research and development services in the fields of medicine and health; research and development in the pharmaceutical and biotechnology fields; biological, scientific, clinical and medical research and development; drug discovery services; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of compounds for use in targeted pharmaceutical therapies; medical and pharmacological research services; research relating to molecular sciences and biotechnology; research and development in the field of microorganisms and cells; research and development in the field of therapeutics; scientific and medical research services in the field of microbiome modulating therapeutics; research and development of pharmaceutical preparations for the treatment of gastrointestinal disorders and diseases; research and development of biological drug delivery platforms; biochemical research and analysis; bacteriological research and analysis; analysis in the field of intestinal microbiology; analysis of human excreta for medical research; microbiological testing; biological analysis; research, development, analysis and evaluation services in connection with biotechnology, microorganisms, cells, pharmaceuticals, medicine, molecular sciences, bacteria, physiology, biology, genetics, genomics, microbiome, metabolomics, proteomics, glycomics, biochemistry, probiotics, prebiotics, nutraceutical supplements, health, wellness, physical well-being, mental well-being, exercise, weight planning, weight management, diet, nutrition and/or sleep; research, development, analysis and evaluation services in connection with microbiology, genetics, the human immune system, the human gut microbiome or gastrointestinal health; DNA screening for scientific research purposes; testing of pharmaceuticals; testing, authentication and quality control; biotechnology and chemical testing; development of biochemical reagents; laboratory services; clinical research; clinical trials; conducting early evaluations in the field of new pharmaceuticals; research and development for use in clinical trials; providing information about the results of clinical trials for pharmaceutical products; diagnostic and testing services; structural and functional analysis of genomes; services for assessing the efficiency of medical and veterinary drugs; veterinary research and development services; product design and development; design services relating to the biotechnology industry; analysis of product development; pharmaceutical product evaluation; preparation of reports in the field of biotechnology and/or gut health; scientific research and analysis; scientific research project management; scientific risk assessment; industrial analysis and research; analysis of product design; technical data analysis; consultancy, information and advisory services relating to all of the aforesaid services. | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 15, 2026 | IROP | IRREGULARITY ON NOTICE OF POSSIBLE OPPOSITION RECEIVED FROM IB | — |
| Jun 1, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 31, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 19, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 17, 2025 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 17, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 22, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 4, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 4, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 15, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 14, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 3, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 3, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |